Thursday, 29 August 2019

AstraZeneca lupus drug meets main goal in study

AstraZeneca Plc said on Thursday its experimental drug to treat moderate-to-severe lupus, anifrolumab, met its main goal in a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)